Johnson and Johnson announces one billion dollar investment for new Pennsylvania facility
J&J will build a cell therapy plant in Pennsylvania to expand its domestic manufacturing. The project aims to create five hundred permanent local jobs.
Insights:
Johnson & Johnson announced on February 18, 2026, that it will invest more than $1 billion to build a new cell therapy facility (Montgomery County, Pennsylvania). This project is intended to expand the company's capacity for medicines targeting cancer, immune disorders, and neurological diseases. According to the company, the development will create over 4,000 construction jobs and about 500 permanent biomanufacturing jobs, providing a significant boost to the regional workforce.
